Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

This grant funds P50 Specialized Programs of Research Excellence to support investigator-initiated translational research on human cancers, aiming to improve prevention, early detection, diagnosis, or treatment of an organ-specific cancer or related group. Projects must use cellular, molecular, structural, biochemical, or genetic approaches and reach a translational human endpoint.